(Q42542251)

2 November 2017

Systematic analysis of overall survival and interactions between tumor mutations and drug treatment (English)

1 reference

2 November 2017

2

1 reference

2 November 2017

Francesco Gatto

1

0 references

language of work or name

1 reference

2 March 2016

1 reference

Journal of Hematology & Oncology

2 November 2017

1 reference

2 November 2017

9

1 reference

2 November 2017

15

1 reference

Mutational analysis reveals the origin and therapy-driven evolution of recurrent glioma

2 November 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4774108

Lessons from the cancer genome

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4774108

Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4774108

Genome sequencing identifies a basis for everolimus sensitivity

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4774108

The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4774108

Systematic identification of genomic markers of drug sensitivity in cancer cells

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4774108

IDH1 or IDH2 mutations predict longer survival and response to temozolomide in low-grade gliomas.

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4774108

IDH1 mutations in low-grade astrocytomas predict survival but not response to temozolomide

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4774108

Prognostic impact of molecular phenotype in patients with recurrent anaplastic glioma treated with prolonged administration of temozolomide.

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4774108

Prognostic factors for survival in adult patients with cerebral low-grade glioma.

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4774108

10.1186/S13045-016-0249-2

16 August 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

2 November 2017

1 reference

9 September 2019

https://scigraph.springernature.com/pub.10.1186/s13045-016-0249-2

1 reference

2 November 2017

PubMed publication ID

26936071

1 reference